CN1281271C - Biological bacteria inhibitor - Google Patents
Biological bacteria inhibitor Download PDFInfo
- Publication number
- CN1281271C CN1281271C CNB2004100244002A CN200410024400A CN1281271C CN 1281271 C CN1281271 C CN 1281271C CN B2004100244002 A CNB2004100244002 A CN B2004100244002A CN 200410024400 A CN200410024400 A CN 200410024400A CN 1281271 C CN1281271 C CN 1281271C
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- chlorhexidine gluconate
- chlorhexidine digluconate
- polyglycopeptide
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000894006 Bacteria Species 0.000 title abstract description 9
- 239000003112 inhibitor Substances 0.000 title abstract 4
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 55
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims description 19
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims description 19
- 229920001231 Polysaccharide peptide Polymers 0.000 claims description 17
- 108010022457 polysaccharide peptide Proteins 0.000 claims description 17
- 241000222122 Candida albicans Species 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 11
- 229940095731 candida albicans Drugs 0.000 claims description 10
- 239000000022 bacteriostatic agent Substances 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 210000004698 lymphocyte Anatomy 0.000 abstract description 5
- 210000002540 macrophage Anatomy 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 230000003511 endothelial effect Effects 0.000 abstract description 2
- 230000000242 pagocytic effect Effects 0.000 abstract description 2
- 210000004976 peripheral blood cell Anatomy 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 abstract 4
- 238000004140 cleaning Methods 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 208000000143 urethritis Diseases 0.000 description 5
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000002003 vulvitis Diseases 0.000 description 3
- XWBADQOPXPRKBX-FMIVXFBMSA-N 1-n,1-n-diethyl-4-n-[6-methoxy-2-[(e)-2-(4-nitrophenyl)ethenyl]quinolin-4-yl]pentane-1,4-diamine Chemical compound N=1C2=CC=C(OC)C=C2C(NC(C)CCCN(CC)CC)=CC=1\C=C\C1=CC=C([N+]([O-])=O)C=C1 XWBADQOPXPRKBX-FMIVXFBMSA-N 0.000 description 2
- 206010059313 Anogenital warts Diseases 0.000 description 2
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 2
- 206010004078 Balanoposthitis Diseases 0.000 description 2
- 206010007134 Candida infections Diseases 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003716 antitrichomonal agent Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 201000003984 candidiasis Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100244002A CN1281271C (en) | 2004-07-04 | 2004-07-04 | Biological bacteria inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100244002A CN1281271C (en) | 2004-07-04 | 2004-07-04 | Biological bacteria inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1602955A CN1602955A (en) | 2005-04-06 |
CN1281271C true CN1281271C (en) | 2006-10-25 |
Family
ID=34663479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100244002A Expired - Fee Related CN1281271C (en) | 2004-07-04 | 2004-07-04 | Biological bacteria inhibitor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1281271C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101212906B (en) * | 2005-07-01 | 2011-09-28 | 凯恩生物科技有限公司 | Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices |
CN107326738A (en) * | 2017-06-30 | 2017-11-07 | 广西点图包装有限公司 | Paper product antibacterial finish agent |
CN114766516B (en) * | 2022-04-20 | 2023-06-16 | 四川大学 | Lipopeptide compound antibacterial agent applicable to trichoderma and penicillium on bone cultural relics, and preparation method and application thereof |
-
2004
- 2004-07-04 CN CNB2004100244002A patent/CN1281271C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1602955A (en) | 2005-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101725175B1 (en) | Antimicrobial composition | |
CN108158995A (en) | A kind of gynaecology's anti-bacteria foaming agent containing chitosan and preparation method thereof | |
CN1823813A (en) | Nursing and treating composition for female vagina and its preparation method | |
CN107998461A (en) | A kind of sheath that is exclusively used in has the function of the soluble oil of composite antibacterial | |
CN1788568A (en) | Quick-effective iodine disinfectant and production method thereof | |
CN108404111B (en) | A bacteriostatic and antiviral preparation containing semen Phaseoli vulgaris phytohemagglutinin as main ingredient | |
CN1372974A (en) | Exterior-applied gel contaiing lysozyme as primary component and its preparing process | |
CN1281271C (en) | Biological bacteria inhibitor | |
CN104487054A (en) | Compositions and methods for enhancing the efficacy of contraceptive microbicides | |
CN108926577A (en) | A kind of method that electric potential water is used for Wound antibiotic healing cleaning-nursing | |
CN100592915C (en) | Ecological vagina cleaning bacteriostasis liquid | |
CN106267158A (en) | A kind of wound healing and the gel of reparation cervical mucosa | |
Banerjee et al. | Bees make medicine for mankind | |
RU2390341C2 (en) | Method of conservative treatment of bladder leukoplakia (squamous metaplasia) | |
CN100388949C (en) | Lysostaphin freeze dried powder used for preventing and treating cattle edometritis | |
CN111632073A (en) | Antibacterial and anti-inflammatory female privates probiotic composition and preparation thereof | |
CN1431012A (en) | Externally used Chinese herbal medicine for treating gynecology inflammation | |
CN111631991A (en) | Private nursing lotion | |
CN101249084B (en) | Disinfection composing prescription of preventability transmitted diseases | |
CN1056774C (en) | Keyoulin sterilizing bactericide | |
CN105997858A (en) | Natural protein substance compound lotion | |
CN1270752C (en) | Antiseptic and its processing method | |
CN1528341A (en) | Povidone-iodine foamable composition | |
CN113230390A (en) | Composition, vaginal lotion and application of vaginal lotion in gynecological mucosal injury repair | |
Kaur et al. | Human bite-induced penile ulceration: report of a case and review of literature |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHONGSHENG PHARMACEUTICAL TECHNOLOGY CO., Free format text: FORMER OWNER: ZHONG HOULU Effective date: 20110624 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 563002 INSIDE OF ZUNYI JINLONGKUI BIOTECHNOLOGY DEVELOPMENT CO., LTD., NO. 79, GAOXIANG ROAD, HUICHUAN DISTRICT, ZUNYI CITY, GUIZHOU PROVINCE TO: 200137 ROOM 103, BUILDING 1, NO. 399, XINGNAN ROAD, PUDONG NEW DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110624 Address after: 103 room 399, building /1, No. 200137 South Road, Shanghai, Pudong New Area Patentee after: Shanghai Zhongsheng Pharmaceutical Technology Co., Ltd. Address before: 563002, Zunyi Jinlong Biotechnology Development Co., Ltd., 79 alley Road, Zunyi, Guizhou, Huichuan District Patentee before: Zhong Houlu |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061025 Termination date: 20100704 |